Chronic course of a hemolytic uremic syndrome caused by a deficiency of factor H-related proteins (CFHR1 and CFHR3)

Kidney International

Volumn 74, Issue 3, 2008, Pages 384-388

  Koziolek, Michael J ^a   Zipfel, Peter F ^b   Skerka, Christine ^b   Vasko, Radovan ^a   Gröne, Elisabeth F ^c   Müller, Gerhard A ^a   Strutz, Frank ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED PROTEIN 1; COMPLEMENT FACTOR H RELATED PROTEIN 3; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; METOPROLOL; MOXONIDINE; PARACETAMOL; PREDNISOLONE; VALSARTAN;

ANAMNESIS; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL FEATURE; COMPLEMENT FACTOR H DEFICIENCY; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; GENE DELETION; HEART LEFT VENTRICLE HYPERTROPHY; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY TEST; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 47349088425     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.133     Document Type: Article

References (19)

1. Liu J, Hutzler M, Li C et al. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking. J Thromb Thrombolysis 2001; 11: 261-272.
2. Remuzzi G, Galbusera M, Mannucci PM. ADAMTS13 in microangiopathies. Blood 2002; 100: 3842.
3. George JN. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-1935.
4. Gasser C, Gautier C, Steck A et al. Hämolytisch- urämisches Syndrom: bilaterale Nierenrindennekrosen bei akuten erworbenen hämolytischen Anämien. Schweiz Med Wochenschr 1955; 85: 905-909.
5. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 1995; 47: 2-19.
6. Noris M, Remuzzi G. Non-shiga toxin-associated hemolytic uremic syndrome. In: Zipfel P (ed). Complement and Kidney Disease. Birkhauser-Verlag: Basel, 2005, pp 65-83.
7. Amirlak I, Amirlak B. Hemolytic uraemic syndrome: an overview. Nephrology (Carlton) 2006; 11: 213-218.
8. Hosler GA, Cusumano AM, Hutchins GM. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med 2003; 127: 834-839.
9. Kavanagh D, Goodship TH, Richards A. Atypical hemolytic uraemic syndrome. Br Med Bull 2006; 77-78: 5-22.
10. Mitra D, Jaffe EA, Weksler B et al. Thrombotic thrombocytopenic purpura and sporadic hemolytic uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 1997; 89: 1224-1234.
11. Caprioli J, Noris M, Brioschi S et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006; 108: 1267-1279.
12. Zipfel PF, Skerka C. Complement dysfunction in hemolytic uremic syndrome. Curr Opin Rheumatol 2006; 18: 548-555.
13. Zipfel PF, Heinen S, Jozsi M et al. Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol Immunol 2006; 43: 97-106.
14. McRae JL, Duthy TG, Griggs KM et al. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J Immunol 2005; 174: 6250-6256.
15. Monteferrante G, Brioschi S, Caprioli J et al. Genetic analysis of the complement factor H related 5 gene in hemolytic uraemic syndrome. Mol Immunol 2006; 44: 1704-1708.
16. Zipfel PF, Jokiranta TS, Hellwage J et al. The factor H protein family. Immunopharmacology 1999; 42: 53-60.
17. Zipfel PF, Edey M, Heinen S et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet 2007; 3: 387-392.
18. Dragon-Durey MA, Loirat C, Cloarec S et al. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16: 555-563.
19. Hellwage J, Jokiranta TS, Koistinen V et al. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin. FEBS Lett 1999; 462: 345-352.